Marker Therapeutics, Inc. (MRKR)
$0.92-8.91%Close
SELLCRISIS · day 13
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10M
- Beta
- 1.53
- P/E (TTM)
- -1.93
- Short % float
- 1.63%
- Days to cover
- 2.5
- SI change
- -25.5%
- 1W
- -8.91%
- 1M
- -21.37%
- vs SPY 1W
- -9.33%
- vs SPY 1M
- -23.43%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on MRKR?
- LOPJLB’s latest quantitative signal on Marker Therapeutics, Inc. (MRKR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is MRKR in?
- Marker Therapeutics, Inc. (MRKR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Marker Therapeutics, Inc. (MRKR) do?
- Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-edge treatments are engineered to address both blood cancers (hematological malignancies) and solid tumor conditions across the United States. A cornerstone of their approach is the proprietary Mul…